CD133 (AC133) expression on AML cells and progenitors

References

• Lapidot T, Sirard C, Vormoor J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994;367:645–8.
   PubMed Web of Science ®Google Scholar
• Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med 1997;3:730–6.
   PubMed Web of Science ®Google Scholar
• Sutherland HJ, Blair A, Zapf RW. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells. Blood 1996;87:4759–61.
   Google Scholar
• Blair A, Hogge DE, Sutherland HJ. Most acute myeloid leukaemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34-7 CD71- /HLA-DR- . Blood 1998;92: 4325–35.
   Google Scholar
• Blair A, Hogge DE, Ailles LE et al. Lack of expression of Thy-1 (CD90) on acute myeloid leukaemia cells with long-term proliferative ability in vitro and in vivo. Blood 1997;89: 3104–12.
   PubMed Web of Science ®Google Scholar
• Blair A, Sutherland HJ. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit. Exp Hematol 2000; 28:660–71.
   PubMed Web of Science ®Google Scholar
• Miraglia S, Godfrey W, Yin AH et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997;90: 5013–21.
   PubMed Web of Science ®Google Scholar
• de Wynter EA, Buck D, Hart C et al. CD34 + CD133+ cellsisolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 1998;16:387–96.
   PubMed Web of Science ®Google Scholar
• Corbeil D, Roper K, Hellwig A et al. The human CD133 hematopoietic stem cell antigen is also expressed in epithe-lial cells and targeted to plasma membrane protrusions. I Biol Chem 2000;275:5512–20.
   Google Scholar
• Yin AH, Miraglia S, Zanjani ED et at CD133, a novel marker for human hematopoietic stem and progenitors cells. Blood 1997;90:5002–12.
   PubMed Web of Science ®Google Scholar
• Zanjani ED, Almeida-Porada G, Livingston AG et al. Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34 + cells. Exp Hematol 1998;26:353–60.
   PubMed Web of Science ®Google Scholar
• Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick J. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nature Med 1998;4:1038–45.
   Google Scholar
• Gallacher L, Murdoch B, Wu DM et al. Isolation and characterization of human CD34- Lin- and CD34 + Lin hematopoietic stem cells using cell surface markers CD133 and CD 7 . Blood 2000;95:2813–20.
   PubMed Web of Science ®Google Scholar
• Kratz-Albers K, Zühlsdorf M, Leo R et al. Expression of CD133, a novel stem cell marker, on human leukemic blasts lacking CD34- antigen and on a human CD34 + leukemic cell line: MUTZ-2. Blood 1998;92:4485–7.
   PubMed Web of Science ®Google Scholar
• Horn PA, Tesch H, Staib Petal. Expression of CD133, a novel hematopoietic precursor antigen, on acute myeloid leukemia cells. Blood 1999;93: 1435–7.
   Google Scholar
• Bühring H-J, Seiffert M, Marxer A et al. CD133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34 + B-cell precursors. Blood 1999;94:832–3.
   Google Scholar
• Snell V, Jackson E, Buck D, Andreeff M. Expression of the CD133 antigen in leukemic and normal progenitors [abstract]. B/ood1998;92:119a.
   Google Scholar
• Fraser C, Eaves CJ, Kalousek DK. Fluorodeoxyuridine syn-chronization of hemopoietic colonies. Cancer Genet Cytogenet 1987;24:1–6.
   PubMed Web of Science ®Google Scholar
• Lau YF, Huang JC, Dozy AM, Kan YW. A rapid screening test for antenatal sex determination. Lancet 1984;14–16.
   Google Scholar
• Grimwade D, Walker H, Oliver F et al. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1612 patients entered into the MRC AML 10 trial. Blood 1998;92:2322–33.
   PubMed Web of Science ®Google Scholar
• Campos L, Guyo tat D, Archimbaud E et al. Clinical signifi-cance of multidrug resistance P-glycoprotein expression on acute nonlymphoblasic leukemia cells at diagnosis. Blood 1992;79:473–6.
   PubMed Web of Science ®Google Scholar
• Raspadori D, Lauria F, Ventura MA et al. Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis of 141 cases. Leuk Res 1997; 21:603–7.
   PubMed Web of Science ®Google Scholar
• Lee EJ, Yang J, Leavitt RD et al. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia. Leukemia 2000;6:1203–9.
   Google Scholar
• Ailles LE, Gerhard B, Kawagoe H, Hogge DE. Growth char-acteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/ severe combined immunodeficient mice. Blood 1999;94: 1761–72.
   PubMed Web of Science ®Google Scholar
• Waller CF, Martens UM, Lange W. Philadelphia chromo-some-positive cells are equally distributed in CD133+ and CD133- fractions of CD 34 peripheral blood progenitor cells from patients with CML. Leukemia 1999;13: 1466–7.
   Google Scholar
• Terpstra W, Prins A, Ploemacher RE et al. Leukemia initi-ating capacity of the CD34 negative subset of acute myeloid leukemic in SCID mice [abstract]. Exp Hematol 1995;23:753.
   Google Scholar